|
|
Scholarly Publications
For many years Dr. Boas has been at the forefront of scholarly research into cystic
fibrosis and other pulmonary conditions. He has authored over 25 journal articles
in a broad spectrum of highly respected publications. Dr. Boas is on the leading
edge of all advances in CF care.
JOURNAL
ARTICLES
1.
Osiecki-Newman K, Fabbro D, Dinu T, Boas SR, Gatt S, Legler
G, Desnick R,
and
Grabowski G. Human Acid Beta Glucosidase : Affinity purification of
the
normal
and Gaucher splenic enzymes on n-alkyl deoxynorjirmycin sepharose.
Enzyme
1986; 35:147-153.
2.
Boas SR,
Noyes BE, Kurland G, Armitage J, and Orenstein DM. Pediatric lung
transplantation
for graft-versus-host disease following bone marrow transplant.
Chest
1994; 105:1584-1586.
3.
Boas
SR,
Charron M, Ledesma-Medina J, Noyes BE, and Kurland G.
Hypertrophic
osteoarthropathy in a child with follicular bronchiolitis. Clin
Nuclear
Med
1995; 20(1):49-51.
4.
Boas
SR,
Falsetti D, Murphy TD, and Orenstein DM. Validity of self-assessment
of
sexual maturation in adolescents with cystic fibrosis. J Adoles
Health 1995;
17:42-45.
5.
Faro A, Kurland G, Michaels MG, Dickman PS, Greally PG, Spichty KJ,
Noyes
BE,
Boas SR, Fricker J, Armitage J, and Zeevi A. Alpha-interferon
affects the
immune
response in post transplant lymphoproliferative disorder. Am J
Respir
Crit
Care Med 1996; 153:1442-1447.
6.
Boas
SR,
Cleary DA, Lee PA, Orenstein DM. Salivary testosterone levels
in
male
adolescents with cystic fibrosis. Pediatrics 1996; 97:361-363.
7.
Boas
SR,
Bloom MD, and Bonilla JA. Infantile laryngeal neurofibroma
presenting
as
stridor and dysphagia. Clin Pediatrics 1996; 35:151-153.
8.
Boas
SR,
Joswiak ML, Nixon PA, Fulton JA, and Orenstein DM. Factors limiting
anaerobic
performance in adolescent males with cystic fibrosis. Med Sci Sports
Exerc
1996; 28:291-298.
9.
Boas
SR,
Kurland G, Greally PG, and Motoyama EK. Evolution of airway
hyperresponsiveness
in congenital diaphragmatic hernia. Pediatr Pulmonol
1996;
22:295-304.
10.
Boas SR,
Joswiak ML, Kurland G, Nixon PA, O'Connor MJ, Bufalino K,
Orenstein
DM, and Whiteside TL. Effects of anaerobic exercise on the
immune
system
in 8 to 17 year old trained and untrained males. J Pediatr 1996;
129:846-855.
11. Zapletal A, Kurland G, Boas SR, Noyes BE, Greally
PG, Faro A, Armitage JM,
and
Orenstein DM. Airway function tests and vocal cord paralysis in lung
transplant
recipients. Pediatr Pulmonol 1997; 23:87-94.
12.
Boas SR.
Exercise recommendations in individuals with cystic fibrosis. Sports
Med
1997; 24:17-37.
13.
Boas SR,
Fulton JA, Koehler AN, Orenstein DM. Nutritional and pulmonary
function
predictors of delayed puberty in adolescent males with cystic
fibr;
Clin
Pediatrics 1998; 37:593-596.
14. Saini SK, Boas SR, Jerath A, Roberts M,
Greenberger PA. Allergic
bronchopulmonary
mycosis to Fusarium vasinfectum in a child. Ann Allergy
Asthma
Immunol 1998; 80:377-80.
15.
Boas SR,
Danduran MJ, Saini SK. Anaerobic exercise testing in children with
asthma. J
Asthma 1998; 35:481-487.
16.
Boas SR,
Danduran MJ, McColley SA. Parental attitudes about exercise in
cystic
fibrosis. Int J Sports Med 1999; 20:334-338.
17.
Boas SR,
Danduran MJ, McColley SA. Energy metabolism during anaerobic
exercise
in children with cystic fibrosis and asthma. Med Sci Sports Exerc
1999;
31:1242-1249.
18. Danduran MJ and Boas SR. Cystic fibrosis and
exercise: A case study and
clinical
application. Il Fysioterapista 2000; 6:36-41.
19.
Boas SR,
Danduran MJ, McColley SA, Beeman K, O’Gorman MRG. Immune
modulation
following aerobic exercise in children with cystic fibrosis. Int J
Sports
Med
2000; 21:294-301.
20. McColley SA, Stellmach V, Boas SR, Jain M,
Crawford SE. Serum vascular
endothelial
growth factor is elevated in cystic fibrosis and decreases with
treatment
of pulmonary exacerbation. Am J Resp Crit Care Med 2000;
161:1877-1880.
21.
Boas SR,
Danduran MJ, McColley SA, McBride A, Crawford S, O’Gorman MRG.
Post
exercise immune correlates in children with and without cystic
fibrosis.
Med
Sci Sports Exerc 2000; 32:1997-2004.
22. Bare A, Vankoski SJ, Dias L, Danduran M, Boas S. Independent
ambulators
with
high sacral myelomenigocele: the relation between walking kinematics
and
energy
consumption. Dev Med Child Neurol 2001; 43 (1):16-21.
23.
Boas SR,
Nevin MA. The role of exercise in the diagnosis and management of
children
with pulmonary disorders. Int Sports Med Journal 2001; 2(5).
24. Paridon SM, Alpert BS, Boas SR, et al. Clinical
Stress Testing in the Pediatric
Age
Group. A Statement from the American Heart Association Council on
Cardiovascular
Disease in the Young, Committee on Atherosclerosis,
Hypertension,
and Obesity in Youth. Circulation 2006: 113: 1-15.
25. Boas SR. The Evidence for Exercise. Pediatr Pulmonol 2008: S31:161-163.
26. Boas SR, Hageman JR, Ho LT, Liveris M. Very high-dose ergocalciferol is
effective for correcting vitamin D deficiency in children and young adults with
cystic fibrosis. Journal of Cystic Fibrosis 2009: 9:270-272.
27. Wooldridge JL, Heubi JE, Amaro-Galvez R, Boas SR, et al. Eur-1008
Pancreatic enzyme replacement is safe and effective in patients with cystic
fibrosis and pancreatic insufficiency. Journal of Cystic Fibrosis 2009 (In Press).
28. Katz BZ, Boas S, Shiraishi Y, Mears CJ, Taylor R. Exercise tolerance testing
in a prospective cohort of adolescents with chronic fatigue syndrome and
recovered controls following infectious mononucleosis.
J Pediatrics 2010 (In Press).
^
Top of Page
BOOKS AND BOOK CHAPTERS
Boas SR
and Danduran MJ. Chapter 21: Cystic Fibrosis and Exercise. In:
Clinical
Exercise Physiology. Jon Ehrman (Ed). Champaign, IL:
Human Kinetics 2003.
Boas SR
and Winnie
GB. Chapter 380: Emphysema and Overinflation. In: Nelson
Textbook of Pediatrics, Richard Behrman (Ed). Philadelphia,
PA: WB Saunders
2004, 17th Edition.
Winnie GB and Boas SR. Chapter 381: Alpha 1 Anti-trypsin
Deficiency and
Emphysema. In: Nelson Textbook of Pediatrics, Richard Behrman
(Ed).
Philadelphia, PA: WB Saunders 2004, 17th Edition.
Boas SR. Chapter
382: Bronchiolitis Obliterans. In: Nelson Textbook of Pediatrics,
Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2004, 17th
Edition.
Boas SR.
Chapter 409: Skeletal Disease Influencing Pulmonary Function. In:
Nelson Textbook of Pediatrics, Richard Behrman
(Ed). Philadelphia, PA: WB
Saunders 2004, 17th Edition.
Boas SR
and Winnie
GB. Chapter 389: Emphysema and Overinflation. In: Nelson
Textbook of Pediatrics, Robert Kliegman et al
(Ed). Philadelphia, PA: WB Saunders
2007, 18th Edition.
Winnie GB and Boas SR. Chapter 390: Alpha 1 Anti-trypsin
Deficiency and
Emphysema. In: Nelson Textbook of Pediatrics, Robert Kliegman
et al (Ed).
Philadelphia, PA: WB Saunders 2007, 18th Edition.
Boas SR. Chapter
391: Bronchiolitis Obliterans and Other Distal Airway Disease. In:
Nelson Textbook of Pediatrics, Robert Kliegman et al
(Ed). Philadelphia, PA: WB
Saunders 2007, 18th Edition.
Boas SR. Chapter
416: Skeletal Disease Influencing Pulmonary Function. In:
Nelson Textbook of Pediatrics, Robert Kliegman et al
(Ed). Philadelphia, PA: WB
Saunders 2007, 18th Edition.
PROCEEDINGS AND
NON-REFEREED PAPERS
1997 Boas, S.R. and S.A. McColley. Advances
in Cystic Fibrosis. The Child’s
Doctor 1997; 15.
EXHIBITS
AND AUDIO VISUAL MATERIAL
1995
Boas, S.R. Cystic Fibrosis and Exercise. (A Parent Educational
Booklet).
1998 Boas, S.R.
Pediatric Flexible Bronchoscopy. A guide for patients and
families. (Educational Brochure)
1999 Boas, S.R.
Exercise Induced Asthma. (A Parent Educational Booklet).
2002 Cystic Fibrosis
Update - a Bimonthly Educational Newsletter - begins
ongoing publication
2002 Unique Challenges in
School for CF (Newsletter)
2002 Exercise Induced
Vocal Cord Dysfunction - A Guide for Patients & Parents
2003 Inhaled Glutathione (Newsletter)
2003 Eating Made Easier - A Parent
Guide to Enhancing your Youngster’s
Mealtime Behavior
2003 Pectus Excavatum - An
Educational Brochure on Pectus Excavatum:
Diagnosis, Surgery, Non Surgical Approaches.
2004 Gene Therapy for CF: An Update
(Newsletter)
2004 Inhaled Corticosteroids Use in
Asthma: Things to Consider (Newsletter)
2004 Infection Control in Cystic
Fibrosis
2006 Pediatric Resident Curriculum
^ Top of Page
PUBLISHED ABSTRACTS
Dr. Boas has conducted significant research on cystic fibrosis and other
pulmonary conditions. He has presented his findings at over 45 national and
international conferences. He is one of the most sought after speakers in the field.
1.
Boas SR,
Kurland G, Noyes BE, Orenstein DM, Atlas AB, and Armitage J.
Pneumothorax
after transbronchial biopsy in pediatric lung and heart-lung
transplant
recipients. Am Rev Respir Dis 1993; 147:(4) A607. (Presented at the
1993
American Thoracic Society Annual Conference).
2.
Boas SR,
Greally P, Kurland G, and Motoyama E. Development of airway
reactivity
in neonates with congenital diaphragmatic hernia. Am Rev Respir Dis
1994,
149:(4) A728. (Presented at the 1994 American Thoracic Society
Annual
Conference).
3.
Zapletal A, Greally P, Murphy TD, Boas SR, Faro A, Orenstein
D, Kurland G,
and
Armitage J. Airway function tests in the assessment of vocal
cord
abnormalities
in pediatric heart-lung and double-lung transplant recipients. Am
Rev
Respir Dis 1994, (4) A738. (Presented at the 1994 American Thoracic
Society
Annual Conference).
4.
Greally P, Zapletal A, Boas SR, Orenstein DM, and Armitage
J. Longitudinal
responses
to beta agonists in pediatric heart lung and double lung transplant
recipients. Am
Rev Respir Dis 1994, 149:(4) A732. (Presented at the 1994
American
Thoracic Society Annual Conference).
5.
Boas
SR,
Joswiak ML, Bufalino K, O'Connor MJ, Nixon PA, Orenstein DM, and
Whiteside
TL. Effects of anaerobic exercise on the immune system in 8 to 17
year
old trained and untrained males. Med Sci Sports Exerc 1995, 27(5)
Supplement.
(Presented at the 1995 American College of Sports Medicine
Annual
Conference).
6.
Boas
SR,
Nixon PA, Joswiak M, Fulton J, and Orenstein DM. Anaerobic
exercise
testing in male adolescents with cystic fibrosis. Ped Ex Sci
1995,7(1)
:111.
(Presented at the 1995 North American Society for Pediatric Exercise
Medicine
Annual Conference).
7.
Fulton J, Boas S, Koehler A, and Orenstein D. Nutritional and
respiratory
markers
for pubertal development in adolescent males with cystic fibrosis.
Ped
Pulm
1995, S12: 265. (Presented at the 1995 North American Cystic
Fibrosis
Foundation
National Conference).
8.
Danduran MJ, Boas SR, McColley SA, Gargan J, Wessel HU. Parental
attitudes
about
the benefits and barriers of exercise in children with CF. Ped Pulm
1996,
S336-7.
(Presented at the 1996 North American Cystic Fibrosis Foundation
National
Conference).
9. Sanai S, Boas SR, Danduran MJ. Normal
anaerobic exercise capacity in well-
controlled
asthmatic children. (Presented at the 1997 American Academy of
Pediatrics,
Section on Allergy and Immunology, 1997 Illinois Society of Allergy,
Asthma,
and Immunology).
10. Sanai SK, Boas SR, Danduran MJ. Altered anaerobic
exercise capacity in
asthmatic
children may contribute to impaired exercise tolerance. J Allergy
Clin
Immun
1997;99:1672 (Presented at the 1997 AAAAI/AAI/CIS Joint Meeting).
11.
Boas SR,
Danduran MJ. Parental understanding about the role of exercise in
cystic
fibrosis. Am J Resp Crit Care Med 1997,155:A646. (Presented at the
1997
American Thoracic Society Annual Conference).
12.
Boas SR,
Danduran MJ, McColley SA. Preferential use of aerobic pathways
during
anaerobic exercise in cystic fibrosis. Am J Resp Crit Care Med
1997,155:A643. (Presented
at the 1997 Chicago Thoracic Society Scientific
Abstract
Session, 1997 American Thoracic Society Annual Conference).
13.
Boas SR,
Danduran MJ. Correlation of aerobic and anaerobic exercise in
children
with cystic fibrosis. Med Sci Sports Exerc 1997; 29:
S209. (Presented
at
the 1997 American College of Sports Medicine Conference).
14. Bare A, Vankoski S, Dias L, Danduran M, Boas S.
Energy expenditure in
children
with lumbosacral myelomenigocele: What’s the cost of walking?
Develop
Med Child Neurol 1997; 39 (Suppl 75): 18. (Presented at the 1997
American
Academy for Cerebral Palsy and Developmental Medicine Annual
Meeting).
15. Bare A, Vankoski S, Dias L, Danduran M, Boas S.
Energy expenditure in
children
with lumbosacral myelomenigocele: What’s the cost of walking? Gait
and
Posture 1997; 5: 142-143. (Presented at the 1997 North American
Society
for
Gait and Clinic Movement Analysis).
16. Vankowski S, Bare BS, Dias L, Mitchaud S, Danduran M,
Boas S. Energy
expenditure,
kinematics, and the center of mass during walking in children with
lumbosacral
myelomenigocele. Gait and Posture 1997; 6:279-280.
17.
Boas SR,
Salazar JM, Danduran MJ, McColley SA. Effects of “Breakpoints” in
normative
values for pulmonary function in patients with cystic fibrosis. Am J
Resp
Crit Care Med 1998,157:A128 (Presented at the 1998 Chicago Thoracic
Society
Scientific Abstract Session, 1998 American Thoracic Society
Conference).
18.
Boas SR,
Salazar JM, Danduran MJ, McColley SA. Diurnal variations in
pulmonary
function within the cystic fibrosis population. Am J Resp Crit Care
Med
1998,157:A128 (1998 American Thoracic Society Conference).
19.
Boas SR,
Chen RC, Danduran MJ, McColley SA, O’Gorman MRG, Woods JA.
Post
exercise immune modulation in children with cystic fibrosis. Am J
Resp
Crit
Care Med 1998, 157: A128 (Presented at the 1998 Chicago Thoracic
Society
Scientific Abstract Session, 1998 American Thoracic Society
Conference).
20. McColley SA, Boas SR, Jain M, Qualter NA, O’Malley
CA. Patient adherence to
and
treatment satisfaction with an airway clearance technique. Ped Pulm
1998,
Suppl
17:389 (Presented at the 1998 North American Cystic Fibrosis
Foundation
National
Conference).
21. McColley SA, Stellmach V, Potter E, Huang J, Boas SR,
Jain M, Crawford SE.
Serum
vascular endothelial growth factor (VGEF) is elevated in cystic
fibrosis
and
is modulated by treatment of acute pulmonary exacerbations. Ped Pulm
1998,
Suppl 17:317 (Presented at the 1998 North American Cystic Fibrosis
Foundation
National Conference).
22.
Boas SR,
Schulz C, Weissberg-Benchell J, Martini DR, McColley SA.
Psychological
screening in female adolescents with cystic fibrosis. Ped Pulm
1998,
Suppl 17:394 (Presented at the 1998 North American Cystic Fibrosis
Foundation
National Conference).
23.
Boas SR,
Danduran MJ, Woods JA, O’Gorman MRG, McColley SA. Post
exercise
catecholamine induced immunemodulation in children with cystic
fibrosis. Ped
Ex Sci 1999,11(2):180. (1998 North American Society for Pediatric
Exercise
Medicine Conference).
24. Danduran MJ, Boas SR, McBride AL. Biphasic
responses to exercise appear
compromised
in children with chronic pulmonary disorders. Med Sci Sports
Exerc
1999, 31(5):S330. (Presented at the 1999 American College of Sports
Medicine
Annual Conference).
25. McBride AL, Boas SR, Danduran MJ, Crawford, Huang
L, McColley SA. Serum
vascular
endothelial growth factor correlates with fitness level in cystic
fibrosis. Med
Sci Sports Exerc 1999, 31(5):S270. (Presented at the 1999
American
College of Sports Medicine Annual Conference).
26. McColley SA, Schulz C, Qualter N, Boas SR, Jain M,
Goodman DM.
Participation
in an observational study of airway clearance in cystic fibrosis
does
not
influence patient adherence. Ped Pulm 1999, Suppl 19:331. (Presented
at
the
1999 North American Cystic Fibrosis Foundation National Conference).
27. McColley SA, Harris CV, Qualter N, O’Malley C, Boas SR,
Jain M. Predictors of
adherence
to an airway clearance technique in cystic fibrosis. Ped Pulm 1999,
Suppl
19: 332. (Presented at the 1999 North American Cystic Fibrosis
Foundation
National Conference).
28. McColley SA, Singhal A, Boas SR, Goodman
DM. Inhaled colistin for treatment
of
pulmonary exacerbation of cystic fibrosis. Am J Resp Crit Care Med
2000,
161
(3):A73 (Presented at the 2000 American Thoracic Society
International
Conference).
29. McBride AL, Danduran MJ, McColley SA, Boas SR.
Is FEV1 a good predictor
of exercise tolerance in
individuals with cystic fibrosis. Ped Exerc Sci 2001, 13:
87-88. (Presented
at the 2000 North American Society for Pediatric Exercise
Medicine
International Conference).
30. Danduran MJ, McBride AL, Holinger LD, Boas SR. Case
report: Unexplained
dyspnea
in a competitive female swimmer. Ped Exerc Sci 2001, 13: 188
(Presented
at the 2000 North American Society for Pediatric Exercise Medicine
International
Conference).
31.
Boas SR,
Young J, McBride AM, McColley SA. The role of mirtazepine as an
appetite
stimulant in children with cystic fibrosis. Ped Pulm 2000, Suppl 20:
325-
326. (Presented
at the 2000 North American Cystic Fibrosis Foundation National
Conference).
32.
Boas SR,
Salazar JM, McBride AL, Trousil JD. Feasability and tolerance of
simultaneous
exercise and cold air provocation in children with asthma. Am J
Resp
Crit Care Med 2001; 163 (5): A369. (Presented at the 2001 American
Thoracic
Society Annual Conference).
33. McBride AL, Boas SR, Trousil J, McColley SA. The
utility of flow volume loop
analysis
during exercise in children with cystic fibrosis. Med Sci Sports
Exerc
2001,
33(5):S250. (Presented at the 2001 American College of Sports
Medicine
Annual
Meeting).
34. Altemus C, Boas SR, Mesnik. Utilization of
exercise tidal loop analysis in
children
with exercise induced asthma. (Presented at the 2001 World Asthma
Meeting).
35. Miller ML, Boas SR. Evidence for
deconditioning in children with
musculoskeletal pain
syndromes. Arthritis Rheum 2001, 44(9): S171.
(2001 American Rheumatology
Meeting).
36.
Boas SR,
Talley AM, McBride AL, Mesnik MN. Montelukast attenuates
pulmonary
decline during combined cold air/exercise provocations in children
with
mild asthma. Med Sci Sports Exerc 2002, 34(5):S13. (Presented at the
2002
American College of Sports Medicine Annual Meeting).
37. Trivunovic M, Miller ML, Mesnik M, Boas SR. Evidence
for deconditioning in
children
with musculoskeletal pain syndromes. Med Sci Sports Exerc 2002,
34(5):S13. (Presented
at the 2002 American College of Sports Medicine Annual
Meeting).
38. Mesnik MN, Boas SR. Early recovery oxygen
kinetics following a peak
cardiopulmonary
exercise test in children with cystic fibrosis. Med Sci Sports
Exerc
2002, 34(5):S14. (Presented at the 2002 American College of Sports
Medicine
Annual Meeting).
39.
Boas S,
Shoberg D. Quality improvement initiatives in CF health care
delivery:
Preliminary
results. Pediatr Pulm 2004, S 24:350. (Presented at the 2004 North
American
Cystic Fibrosis Foundation National Conference).
40.
Boas S,
Choudhury N, Urben AJ. Impact of CF Genotype on Exercise
Performance.
Pediatr Pulm 2005, S28:306 (Presented at the 2005 North
American
Cystic Fibrosis Foundation National Conference).
41. Bever JC, Boas SR. Use of tidal loop analysis in
suspected pediatric exercise
induced
vocal cord dysfunction. Med Sci Sports Exerc 2006, 38(5):S384.
42.
Boas SR,
Bever J, Bicchinella M, Liveris M. Breathing strategies during
maximal
exercise
testing Is related to lung disease severity for people with
CF. Pediatr
Pulm
2006, S29:353 (Presented at the 2006 North American Cystic Fibrosis
Foundation
National Conference).
43. Bichinnella, Lading K, Ho LT, Boas SR. A high dose
ergocalciferol regimen
corrects
vitamin D deficiency for individuals with cystic fibrosis: A quality
improvement
initiative. Pediatr Pulm 2007, S30:383 (Presented at the 2006 North
American
Cystic Fibrosis Foundation National Conference).
44. Heubi J, Boas SR, Blake K et al. Eur-1008, A PEP,
is safe and effective in cystic
fibrosis
(CF) patients with exocrine pancreatic insufficiency (EPI). Pediatr
Pulm
2007,
S30:392 (Presented at the 2007 North American Cystic Fibrosis
Foundation
National Conference).
45. Boas SR, Hageman J, Liveris M. Haller index does not predict physiologic
abnormalities in children and adolescents with pectus excavatum. Med Sci
Sports Exerc 2008, 40(5):S1455. (Presented at the 2008 American College
of Sports Medicine Annual Meeting).
46. Boas SR, Bicchinella M, Liveris M, Hageman J. A “Normal” FEV1 is a poor
predictor of exercise tolerance in individuals with cystic fibrosis. Pediatr Pulm
2008, S31:384. (Presented at the 2008 North American Cystic Fibrosis
Conference).
47. Katz, BZ, Boas SR, Shiraishi Y, Mears CJ, Taylor R. Exercise tolerance testing
in a prospective cohort of adolescents with chronic fatigue syndrome and
recovered controls following infectious mononucleosis. (Presented at the 2009
Infectious Disease Society Annual Conference).
48. Boas SR, Wolk RL, Wood L, Service A. Use of ultrasonography in body
composition assessment in cystic fibrosis and pediatric patients. Med Sci
Sports Exerc 2010 (In Press, Presented at the 2010 American College of
Sports Medicine Annual Meeting).
^
Top of Page
Read
about our diagnostic testing.
|
|
|
